Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
Clinical trial NCT01893411 · COMPLETED
Trial details
- NCT number
- NCT01893411
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-08-01
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.